Artificial intelligence does not add a pillar to corporate governance. It tests each of the five the board already holds, and the minutes are the evidence of how the board responded.

A board's scarcest asset is its attention. Avancer's heat map rates twelve board duties by AI impact for health systems, medical device and diagnostics companies, pharmaceutical and biotechnology companies, and health plans, adjusts two duties for public companies, and shows how the ratings set the agenda.

When one committee owns artificial intelligence, the rest of the board stops asking about it. A federated model, written into the charters and coordinated by the chair, closes the gaps.

AI will not replace the executive suite, but it will change how officers decide. Boards must ensure that augmented judgment remains independent judgment.

For boards, the question is no longer whether to engage with AI, but how. Four principles draw the series together, and the minutes hold them in place.